Sleep Movement Disorder Drug Market, Global Outlook and Forecast 2022-2028

April 2022 | 67 pages | ID: S643C655CF22EN
Market Monitor Global

Abstracts

Sleep movement disorders are the disorders disrupting during sleep and generally have undesirable verbal or physical behaviors which frequently result in insomnia and daytime fatigue. Movements during sleep are very common, especially among children.

This report contains market size and forecasts of Sleep Movement Disorder Drug in Global, including the following market information:

Global Sleep Movement Disorder Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Sleep Movement Disorder Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Benzodiazepines Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Sleep Movement Disorder Drug include Cardinal Health, Mylan, Teva, Shermco, Vollin Holdings, Allergan, Pfizer, GlaxoSmithKline and BD. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Sleep Movement Disorder Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Sleep Movement Disorder Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Sleep Movement Disorder Drug Market Segment Percentages, by Type, 2021 (%)

• Benzodiazepines
• Opioids
• Anticonvulsants
• Others

Global Sleep Movement Disorder Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Sleep Movement Disorder Drug Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Sleep Movement Disorder Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Sleep Movement Disorder Drug Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Sleep Movement Disorder Drug revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Sleep Movement Disorder Drug revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Cardinal Health
• Mylan
• Teva
• Shermco
• Vollin Holdings
• Allergan
• Pfizer
• GlaxoSmithKline
• BD

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Sleep Movement Disorder Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Sleep Movement Disorder Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL SLEEP MOVEMENT DISORDER DRUG OVERALL MARKET SIZE

2.1 Global Sleep Movement Disorder Drug Market Size: 2021 VS 2028
2.2 Global Sleep Movement Disorder Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Sleep Movement Disorder Drug Players in Global Market
3.2 Top Global Sleep Movement Disorder Drug Companies Ranked by Revenue
3.3 Global Sleep Movement Disorder Drug Revenue by Companies
3.4 Top 3 and Top 5 Sleep Movement Disorder Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Sleep Movement Disorder Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Sleep Movement Disorder Drug Players in Global Market
  3.6.1 List of Global Tier 1 Sleep Movement Disorder Drug Companies
  3.6.2 List of Global Tier 2 and Tier 3 Sleep Movement Disorder Drug Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Sleep Movement Disorder Drug Market Size Markets, 2021 & 2028
  4.1.2 Benzodiazepines
  4.1.3 Opioids
  4.1.4 Anticonvulsants
  4.1.5 Others
4.2 By Type - Global Sleep Movement Disorder Drug Revenue & Forecasts
  4.2.1 By Type - Global Sleep Movement Disorder Drug Revenue, 2017-2022
  4.2.2 By Type - Global Sleep Movement Disorder Drug Revenue, 2023-2028
  4.2.3 By Type - Global Sleep Movement Disorder Drug Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Sleep Movement Disorder Drug Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacies
  5.1.3 Retail Pharmacies
  5.1.4 Online Pharmacies
5.2 By Application - Global Sleep Movement Disorder Drug Revenue & Forecasts
  5.2.1 By Application - Global Sleep Movement Disorder Drug Revenue, 2017-2022
  5.2.2 By Application - Global Sleep Movement Disorder Drug Revenue, 2023-2028
  5.2.3 By Application - Global Sleep Movement Disorder Drug Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Sleep Movement Disorder Drug Market Size, 2021 & 2028
6.2 By Region - Global Sleep Movement Disorder Drug Revenue & Forecasts
  6.2.1 By Region - Global Sleep Movement Disorder Drug Revenue, 2017-2022
  6.2.2 By Region - Global Sleep Movement Disorder Drug Revenue, 2023-2028
  6.2.3 By Region - Global Sleep Movement Disorder Drug Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Sleep Movement Disorder Drug Revenue, 2017-2028
  6.3.2 US Sleep Movement Disorder Drug Market Size, 2017-2028
  6.3.3 Canada Sleep Movement Disorder Drug Market Size, 2017-2028
  6.3.4 Mexico Sleep Movement Disorder Drug Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Sleep Movement Disorder Drug Revenue, 2017-2028
  6.4.2 Germany Sleep Movement Disorder Drug Market Size, 2017-2028
  6.4.3 France Sleep Movement Disorder Drug Market Size, 2017-2028
  6.4.4 U.K. Sleep Movement Disorder Drug Market Size, 2017-2028
  6.4.5 Italy Sleep Movement Disorder Drug Market Size, 2017-2028
  6.4.6 Russia Sleep Movement Disorder Drug Market Size, 2017-2028
  6.4.7 Nordic Countries Sleep Movement Disorder Drug Market Size, 2017-2028
  6.4.8 Benelux Sleep Movement Disorder Drug Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Sleep Movement Disorder Drug Revenue, 2017-2028
  6.5.2 China Sleep Movement Disorder Drug Market Size, 2017-2028
  6.5.3 Japan Sleep Movement Disorder Drug Market Size, 2017-2028
  6.5.4 South Korea Sleep Movement Disorder Drug Market Size, 2017-2028
  6.5.5 Southeast Asia Sleep Movement Disorder Drug Market Size, 2017-2028
  6.5.6 India Sleep Movement Disorder Drug Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Sleep Movement Disorder Drug Revenue, 2017-2028
  6.6.2 Brazil Sleep Movement Disorder Drug Market Size, 2017-2028
  6.6.3 Argentina Sleep Movement Disorder Drug Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Sleep Movement Disorder Drug Revenue, 2017-2028
  6.7.2 Turkey Sleep Movement Disorder Drug Market Size, 2017-2028
  6.7.3 Israel Sleep Movement Disorder Drug Market Size, 2017-2028
  6.7.4 Saudi Arabia Sleep Movement Disorder Drug Market Size, 2017-2028
  6.7.5 UAE Sleep Movement Disorder Drug Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Cardinal Health
  7.1.1 Cardinal Health Corporate Summary
  7.1.2 Cardinal Health Business Overview
  7.1.3 Cardinal Health Sleep Movement Disorder Drug Major Product Offerings
  7.1.4 Cardinal Health Sleep Movement Disorder Drug Revenue in Global Market (2017-2022)
  7.1.5 Cardinal Health Key News
7.2 Mylan
  7.2.1 Mylan Corporate Summary
  7.2.2 Mylan Business Overview
  7.2.3 Mylan Sleep Movement Disorder Drug Major Product Offerings
  7.2.4 Mylan Sleep Movement Disorder Drug Revenue in Global Market (2017-2022)
  7.2.5 Mylan Key News
7.3 Teva
  7.3.1 Teva Corporate Summary
  7.3.2 Teva Business Overview
  7.3.3 Teva Sleep Movement Disorder Drug Major Product Offerings
  7.3.4 Teva Sleep Movement Disorder Drug Revenue in Global Market (2017-2022)
  7.3.5 Teva Key News
7.4 Shermco
  7.4.1 Shermco Corporate Summary
  7.4.2 Shermco Business Overview
  7.4.3 Shermco Sleep Movement Disorder Drug Major Product Offerings
  7.4.4 Shermco Sleep Movement Disorder Drug Revenue in Global Market (2017-2022)
  7.4.5 Shermco Key News
7.5 Vollin Holdings
  7.5.1 Vollin Holdings Corporate Summary
  7.5.2 Vollin Holdings Business Overview
  7.5.3 Vollin Holdings Sleep Movement Disorder Drug Major Product Offerings
  7.5.4 Vollin Holdings Sleep Movement Disorder Drug Revenue in Global Market (2017-2022)
  7.5.5 Vollin Holdings Key News
7.6 Allergan
  7.6.1 Allergan Corporate Summary
  7.6.2 Allergan Business Overview
  7.6.3 Allergan Sleep Movement Disorder Drug Major Product Offerings
  7.6.4 Allergan Sleep Movement Disorder Drug Revenue in Global Market (2017-2022)
  7.6.5 Allergan Key News
7.7 Pfizer
  7.7.1 Pfizer Corporate Summary
  7.7.2 Pfizer Business Overview
  7.7.3 Pfizer Sleep Movement Disorder Drug Major Product Offerings
  7.7.4 Pfizer Sleep Movement Disorder Drug Revenue in Global Market (2017-2022)
  7.7.5 Pfizer Key News
7.8 GlaxoSmithKline
  7.8.1 GlaxoSmithKline Corporate Summary
  7.8.2 GlaxoSmithKline Business Overview
  7.8.3 GlaxoSmithKline Sleep Movement Disorder Drug Major Product Offerings
  7.8.4 GlaxoSmithKline Sleep Movement Disorder Drug Revenue in Global Market (2017-2022)
  7.8.5 GlaxoSmithKline Key News
7.9 BD
  7.9.1 BD Corporate Summary
  7.9.2 BD Business Overview
  7.9.3 BD Sleep Movement Disorder Drug Major Product Offerings
  7.9.4 BD Sleep Movement Disorder Drug Revenue in Global Market (2017-2022)
  7.9.5 BD Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Sleep Movement Disorder Drug Market Opportunities & Trends in Global Market
Table 2. Sleep Movement Disorder Drug Market Drivers in Global Market
Table 3. Sleep Movement Disorder Drug Market Restraints in Global Market
Table 4. Key Players of Sleep Movement Disorder Drug in Global Market
Table 5. Top Sleep Movement Disorder Drug Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Sleep Movement Disorder Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Sleep Movement Disorder Drug Revenue Share by Companies, 2017-2022
Table 8. Global Companies Sleep Movement Disorder Drug Product Type
Table 9. List of Global Tier 1 Sleep Movement Disorder Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Sleep Movement Disorder Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Sleep Movement Disorder Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Sleep Movement Disorder Drug Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Sleep Movement Disorder Drug Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Sleep Movement Disorder Drug Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Sleep Movement Disorder Drug Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Sleep Movement Disorder Drug Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Sleep Movement Disorder Drug Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Sleep Movement Disorder Drug Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Sleep Movement Disorder Drug Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Sleep Movement Disorder Drug Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Sleep Movement Disorder Drug Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Sleep Movement Disorder Drug Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Sleep Movement Disorder Drug Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Sleep Movement Disorder Drug Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Sleep Movement Disorder Drug Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Sleep Movement Disorder Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Sleep Movement Disorder Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Sleep Movement Disorder Drug Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Sleep Movement Disorder Drug Revenue, (US$, Mn), 2023-2028
Table 30. Cardinal Health Corporate Summary
Table 31. Cardinal Health Sleep Movement Disorder Drug Product Offerings
Table 32. Cardinal Health Sleep Movement Disorder Drug Revenue (US$, Mn), (2017-2022)
Table 33. Mylan Corporate Summary
Table 34. Mylan Sleep Movement Disorder Drug Product Offerings
Table 35. Mylan Sleep Movement Disorder Drug Revenue (US$, Mn), (2017-2022)
Table 36. Teva Corporate Summary
Table 37. Teva Sleep Movement Disorder Drug Product Offerings
Table 38. Teva Sleep Movement Disorder Drug Revenue (US$, Mn), (2017-2022)
Table 39. Shermco Corporate Summary
Table 40. Shermco Sleep Movement Disorder Drug Product Offerings
Table 41. Shermco Sleep Movement Disorder Drug Revenue (US$, Mn), (2017-2022)
Table 42. Vollin Holdings Corporate Summary
Table 43. Vollin Holdings Sleep Movement Disorder Drug Product Offerings
Table 44. Vollin Holdings Sleep Movement Disorder Drug Revenue (US$, Mn), (2017-2022)
Table 45. Allergan Corporate Summary
Table 46. Allergan Sleep Movement Disorder Drug Product Offerings
Table 47. Allergan Sleep Movement Disorder Drug Revenue (US$, Mn), (2017-2022)
Table 48. Pfizer Corporate Summary
Table 49. Pfizer Sleep Movement Disorder Drug Product Offerings
Table 50. Pfizer Sleep Movement Disorder Drug Revenue (US$, Mn), (2017-2022)
Table 51. GlaxoSmithKline Corporate Summary
Table 52. GlaxoSmithKline Sleep Movement Disorder Drug Product Offerings
Table 53. GlaxoSmithKline Sleep Movement Disorder Drug Revenue (US$, Mn), (2017-2022)
Table 54. BD Corporate Summary
Table 55. BD Sleep Movement Disorder Drug Product Offerings
Table 56. BD Sleep Movement Disorder Drug Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Sleep Movement Disorder Drug Segment by Type in 2021
Figure 2. Sleep Movement Disorder Drug Segment by Application in 2021
Figure 3. Global Sleep Movement Disorder Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Sleep Movement Disorder Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Sleep Movement Disorder Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Sleep Movement Disorder Drug Revenue in 2021
Figure 8. By Type - Global Sleep Movement Disorder Drug Revenue Market Share, 2017-2028
Figure 9. By Application - Global Sleep Movement Disorder Drug Revenue Market Share, 2017-2028
Figure 10. By Region - Global Sleep Movement Disorder Drug Revenue Market Share, 2017-2028
Figure 11. By Country - North America Sleep Movement Disorder Drug Revenue Market Share, 2017-2028
Figure 12. US Sleep Movement Disorder Drug Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Sleep Movement Disorder Drug Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Sleep Movement Disorder Drug Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Sleep Movement Disorder Drug Revenue Market Share, 2017-2028
Figure 16. Germany Sleep Movement Disorder Drug Revenue, (US$, Mn), 2017-2028
Figure 17. France Sleep Movement Disorder Drug Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Sleep Movement Disorder Drug Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Sleep Movement Disorder Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Sleep Movement Disorder Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Sleep Movement Disorder Drug Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Sleep Movement Disorder Drug Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Sleep Movement Disorder Drug Revenue Market Share, 2017-2028
Figure 24. China Sleep Movement Disorder Drug Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Sleep Movement Disorder Drug Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Sleep Movement Disorder Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Sleep Movement Disorder Drug Revenue, (US$, Mn), 2017-2028
Figure 28. India Sleep Movement Disorder Drug Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Sleep Movement Disorder Drug Revenue Market Share, 2017-2028
Figure 30. Brazil Sleep Movement Disorder Drug Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Sleep Movement Disorder Drug Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Sleep Movement Disorder Drug Revenue Market Share, 2017-2028
Figure 33. Turkey Sleep Movement Disorder Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Sleep Movement Disorder Drug Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Sleep Movement Disorder Drug Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Sleep Movement Disorder Drug Revenue, (US$, Mn), 2017-2028
Figure 37. Cardinal Health Sleep Movement Disorder Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Mylan Sleep Movement Disorder Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Teva Sleep Movement Disorder Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Shermco Sleep Movement Disorder Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Vollin Holdings Sleep Movement Disorder Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Allergan Sleep Movement Disorder Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Pfizer Sleep Movement Disorder Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. GlaxoSmithKline Sleep Movement Disorder Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. BD Sleep Movement Disorder Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)